Focus Partners Advisor Solutions’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.8M Sell
13,987
-1,254
-8% -$1.28M 0.14% 79
2026
Q1
$14M Sell
15,241
-997
-6% -$1.01M 0.14% 77
2025
Q4
$17.5M Buy
16,238
+2,828
+21% +$2.7M 0.21% 66
2025
Q3
$11.8M Sell
13,410
-552
-4% -$411K 0.13% 90
2025
Q2
$10.9M Sell
13,962
-1,540
-10% -$1.2M 0.15% 83
2025
Q1
$12.8M Buy
15,502
+3,367
+28% +$2.8M 0.19% 66
2024
Q4
$9.37M Sell
12,135
-1,744
-13% -$1.44M 0.16% 77
2024
Q3
$12.3M Buy
13,879
+994
+8% +$894K 0.26% 52
2024
Q2
$11.7M Buy
12,885
+287
+2% +$230K 0.31% 46
2024
Q1
$9.8M Buy
12,598
+10,000
+385% +$7.12M 0.28% 47
2023
Q4
$1.51M Sell
2,598
-4,843
-65% -$2.83M 0.07% 123
2023
Q3
$4M Buy
7,441
+4,207
+130% +$2.17M 0.19% 58
2023
Q2
$1.52M Buy
3,234
+674
+26% +$283K 0.08% 100
2023
Q1
$879K Buy
2,560
+470
+22% +$159K 0.06% 137
2022
Q4
$765K Sell
2,090
-1,286
-38% -$456K 0.06% 149
2022
Q3
$1.09M Buy
3,376
+448
+15% +$142K 0.06% 142
2022
Q2
$949K Buy
2,928
+579
+25% +$174K 0.08% 122
2022
Q1
$674K Buy
+2,349
New +$605K 0.07% 139

Other funds holding LLY

Focus Partners Advisor Solutions's LLY Position: Q2 2026 in Review

Focus Partners Advisor Solutions reduced its Eli Lilly (LLY) stake by 8.2% in Q2 2026, selling an estimated $1.28M and leaving 13,987 shares worth $16.8M. The position accounts for 0.14% of the portfolio, ranked #79.

Focus Partners Advisor Solutions first reported a position in LLY in Q1 2022 and has held it in 18 quarters since. The position peaked at $17.5M in Q4 2025. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Focus Partners Advisor Solutions held 13,987 shares of Eli Lilly worth $16.8M as of Q2 2026.
  • Focus Partners Advisor Solutions sold 1,254 Eli Lilly shares in Q2 2026, an estimated $1.28M.
  • Eli Lilly made up 0.14% of Focus Partners Advisor Solutions's portfolio in Q2 2026, its #79 holding.
  • Focus Partners Advisor Solutions first reported a position in Eli Lilly in Q1 2022 and has held it in 18 quarters since.
  • Focus Partners Advisor Solutions's Eli Lilly position peaked at $17.5M in Q4 2025.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Focus Partners Advisor Solutions's 13F filing for Q2 2026, filed 6 Aug 2026.